Neogenomics (NEO) Shares Issued: 2009-2025
Historic Shares Issued for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $765,000.
- Neogenomics' Shares Issued fell 35.00% to $765,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 76.72%. This contributed to the annual value of $4.6 million for FY2024, which is 0.48% up from last year.
- Per Neogenomics' latest filing, its Shares Issued stood at $765,000 for Q3 2025, which was up 164.67% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, Neogenomics' Shares Issued registered a high of $6.4 million during Q1 2022, and its lowest value of -$1.2 million during Q2 2025.
- Its 3-year average for Shares Issued is $891,000, with a median of $949,000 in 2025.
- As far as peak fluctuations go, Neogenomics' Shares Issued skyrocketed by 2,013.98% in 2024, and later plummeted by 160.17% in 2025.
- Quarterly analysis of 5 years shows Neogenomics' Shares Issued stood at $3.0 million in 2021, then tumbled by 37.58% to $1.9 million in 2022, then plummeted by 31.28% to $1.3 million in 2023, then slumped by 46.08% to $687,000 in 2024, then tumbled by 35.00% to $765,000 in 2025.
- Its Shares Issued was $765,000 in Q3 2025, compared to -$1.2 million in Q2 2025 and $949,000 in Q1 2025.